194 related articles for article (PubMed ID: 20933042)
1. Public vaccination programmes against hepatitis B in The Netherlands: assessing whether a targeted or a universal approach is appropriate.
Houweling H; Wittevrongel CF; Verweij M; Ruitenberg EJ;
Vaccine; 2010 Nov; 28(49):7723-30. PubMed ID: 20933042
[TBL] [Abstract][Full Text] [Related]
2. Preparing for the next public debate: universal vaccination against hepatitis B.
Houweling H; Spaendonck MC; Paulussen T; Verweij M; Ruitenberg EJ
Vaccine; 2011 Nov; 29(48):8960-4. PubMed ID: 21945254
[TBL] [Abstract][Full Text] [Related]
3. [National hepatitis B vaccination closer to implementation, but not soon enough; recommendations from the Dutch Health Council].
Galama JM
Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1339-42. PubMed ID: 11484429
[TBL] [Abstract][Full Text] [Related]
4. Criteria for inclusion of vaccinations in public programmes.
Houweling H; Verweij M; Ruitenberg EJ;
Vaccine; 2010 Apr; 28(17):2924-31. PubMed ID: 20189486
[TBL] [Abstract][Full Text] [Related]
5. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
Mereckiene J; Cotter S; Lopalco P; D'Ancona F; Levy-Bruhl D; Giambi C; Johansen K; Dematte L; Salmaso S; Stefanoff P; O'Flanagan D
Vaccine; 2010 Jun; 28(28):4470-7. PubMed ID: 20451643
[TBL] [Abstract][Full Text] [Related]
7. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
8. [National hepatitis B vaccination closer to implementation, but not soon enough: recommendations from the Dutch Health Council].
Gunning-Schepers LJ; Houweling H
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1572-3. PubMed ID: 11525094
[No Abstract] [Full Text] [Related]
9. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
Van Damme P; Vorsters A
J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk].
de Man RA
Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2365-6. PubMed ID: 18019211
[TBL] [Abstract][Full Text] [Related]
12. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
[TBL] [Abstract][Full Text] [Related]
13. The worldwide impact of vaccination on the control and protection of viral hepatitis B.
Romano' L; Paladini S; Van Damme P; Zanetti AR
Dig Liver Dis; 2011 Jan; 43 Suppl 1():S2-7. PubMed ID: 21195368
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
15. [Protection of children born to hepatitis-B-infected mothers].
Boot HJ; Vermeer-de Bondt PE; Kimman TG
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1816-8. PubMed ID: 15495509
[TBL] [Abstract][Full Text] [Related]
16. Global progress toward universal childhood hepatitis B vaccination, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in countries with low endemicity.
Prescrire Int; 2000 Feb; 9(45):213-9. PubMed ID: 11503803
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
19. [Health Council report 'Protection against hepatitis B': an opportunity for effective prevention through cooperation].
Schalm SW
Ned Tijdschr Geneeskd; 1997 Feb; 141(7):315-7. PubMed ID: 9132603
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.
Rots NY; Wijmenga-Monsuur AJ; Luytjes W; Kaaijk P; de Graaf TW; van der Zeijst BA; Boog CJ
Vaccine; 2010 Jan; 28(4):893-900. PubMed ID: 19932217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
